Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 26, 2015

View Archived Issues

Studies support switching to infliximab biosimilar for Crohn's disease and ulcerative colitis

Ferring Pharmaceuticals acquires drug delivery technology from CTCBIO

PaQ device improves glycemia control in patients with diabetes

InSys in-licenses novel therapy for chronic pelvic pain syndrome

CymaBay reports phase IIb results for arhalofenate in gout

Pfizer releases results from phase II trial of Trumenba administered with other vaccines in children

Endpoints met in Teva's phase IIb study of TEV-48125 for prevention of chronic migraine

Novel TNKS1/2 inhibitor shows potential for in vivo inhibition of Wnt pathway

Phase III SUMMIT-07 study of NKTR-181 begins in patients with chronic low back pain

MicuRx begins U.S. phase II trial of MRX-I

Bristol-Myers Squibb to acquire Flexus Biosciences

Favipiravir evaluated in phase II Ebola virus disease trial

N30 Pharmaceuticals changes name to Nivalis Therapeutics

First launch of Takecab in Japan

Regen BioPharma updates development progress of dCellVax

FDA approves Avycaz for cIAI and cUTI

Fujian Haixi Pharmaceuticals patent reports development of BTK inhibitors

Takeda describes FFA1 receptor agonists for diabetes

Roche patents compounds for treatment of RSV

Wee1-like protein kinase inhibitors prepared and tested at Almac Discovery

Merck & Co. synthesizes new orexin OX2 receptor antagonists

NICE issues final guidance on biologic therapies for ulcerative colitis

Medicago awarded Ebola antibody contract by BARDA

Shionogi starts phase III trial of peptide vaccine S-588410 for esophageal cancer

EMA awards orphan drug designation to alvocidib for AML

NGM and Merck & Co. to discover, develop and commercialize novel biologic therapeutics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...